Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression

D. S. Fomina; S. S. Andreev; G. V. Andrenova; T. S. Kruglova; D. M. Demidchik; O. S. Kovalevskaya; Z. Yu. Mutovina; E. A. Dokukina; O. V. Filon; A. V. Petkova; E. K. Khanonina; M. Yu. Samsonov

PULMONOLOGIYA
Russian Pulmonology Journal

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

User

eng | рус

PULMONOLOGIYA

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Fomina D.S., Andreev S.S., Andrenova G.V., Kruglova T.S., Demidchik D.M., Kovalevskaya O.S., Mutovina Z.Yu., Dokukina E.A., Filon O.V., Petkova A.V., Khanonina E.K., Samsonov M.Yu. Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression. PULMONOLOGIYA. 2023;33(5):623-632. (In Russ.) https://doi.org/10.18093/0869-0189-2023-33-5-623-632

Views PDF (Rus): 313

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Aleksandr G. Chuchalin

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

D. S. Fomina
State Budgetary Healthcare Institution of Moscow City “Moscow City Clinical Hospital 52”, Moscow Department of Health; Federal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Non-profit Joint Stock Company “Astana Medical University”, Ministry of Health of the Republic of Kazakhstan
Russian Federation

Daria S. Fomina, Candidate of Medicine, Associate Professor, Allergist-immunologist, Head of Moscow City Scientific and Practical Center of Allergology and Immunology, State Budgetary Healthcare Institution of Moscow City “Moscow City Clinical Hospital 52”, Moscow Department of Health; Associate Professor, Department of Clinical Allergology аnd Immunology, Federal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Professor, Non-profit Joint Stock Company “Astana Medical University”, Ministry of Health of the Republic of Kazakhstan; Chief Specialist, Allergist-Immunologist, Moscow Department of Health

ul. Pekhotnaya 3, Moscow, 123182; ul. Trubetskaya 8, build. 2, Moscow, 119991; ul. Beibitshilik 49a, Nur-Sultan, 010000, Republic of Kazakhstan

tel.: (499) 196-19-54

S. S. Andreev
State Budgetary Healthcare Institution of Moscow City “Moscow City Clinical Hospital 52”, Moscow Department of Health
Russian Federation

Sergey S. Andreev, Head of the Department of Clinical Pharmacology